Dear DEA:
Our country is faced with an obesity epidemic currently in full swing with limited means for physicians to fight this epidemic. Delay is costing lives and billions in costs to address obesity related illnesses. Lorcaserin (Belviq) is the first single agent in history that provides physicians a tool to control this growing danger to our society. Please waive this silly waiting/notice period and make the rule effective immediately! Thank you, in advance, for your attention to this very serious matter.
Comment on FR Doc # 2012-30531
This is comment on Proposed Rule
Schedules of Controlled Substances: Placement of Lorcaserin into Schedule IV
View Comment
Related Comments
View AllPublic Submission Posted: 12/21/2012 ID: DEA-2012-0007-0003
Jan 18,2013 11:59 PM ET
Public Submission Posted: 12/21/2012 ID: DEA-2012-0007-0004
Jan 18,2013 11:59 PM ET
Public Submission Posted: 12/21/2012 ID: DEA-2012-0007-0005
Jan 18,2013 11:59 PM ET
Public Submission Posted: 12/21/2012 ID: DEA-2012-0007-0008
Jan 18,2013 11:59 PM ET
Public Submission Posted: 01/04/2013 ID: DEA-2012-0007-0032
Jan 18,2013 11:59 PM ET